Study implicates abnormalities in SOD1 with Parkinson's disease and ALS.
Researchers have identified a transport defect in models of familial ALS which leads to the accumulation of damaged components.
Researchers have identified a new genetic mutation for amyotrophic lateral sclerosis (ALS), opening the door to future targeted therapies.
